New schizophrenia pill enters human testing
Symptom relief
Recruiting now
This early-stage study tests an experimental oral drug called NTX-253 in healthy volunteers and people with stable schizophrenia. The main goal is to check safety and how the body processes the drug. 73 adults aged 18–55 will take single or multiple doses to find the right dose r…
Phase: EARLY_PHASE1 • Sponsor: Neurosterix • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC